An automated extraction method for extracting the major urinary metabolite of cannabis, 11-nor-Ag-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) was developed on the four-probe Gilson ASPEC XL4 TM solid-phase extraction (SPE) system. The method works on liquid-liquid extraction principles but does not require the use of SPE cartridges. The limits of detection and quantitation and the upper limit of linearity (ULOL) of the developed method were found to be 1, 2, and 1500 ng/mL, respectively. There was no detectable carry over after 10,000 ng/mL analyte. For a batch of 76 samples, the process uses less than 100 mL methanol, 450 mL extracting solvent hexane/ethyl acetate (5:1, v/v) and 1 L rinsing solvent, 30% methanol in water. The automated extraction process takes 5 h to complete. Precision and accuracy of the method are comparable to both manual liquid-liquid extraction and automated SPE methods. The method has proven to be a simple, speedy, and economical alternative to the currently popular automated SPE method for the quantitative analysis of urinary THC-COOH.
Introduction
Cannabis is one of the most widely abused illicit drugs in Australia and in the world (1, 2) . Cannabis use is detected by identifying the presence of metabolites of the major psychoactive constituent of marijuana, Ag-tetrahydrocannabinol (THC) in biological fluids (e.g., urine) (3, 4) . The major metabolite of THC found in urine is 11-nor-Ag-tetrahydrocannabinol-9-carboxylic acid (THC-COOH), which exists in both free and a glucuronide bound form (5, 6) . Analytical procedures are well-documented for determining the presence of THC-COOH in urine using thin-layer chromatography (7), high-performance liquid chromatography (8) , liquid chromatography-mass spectrometry (9), gas chromatography (GC) (10), gas chromatography-mass spectrometry (GC-MS) (11, 12) , and immunoassays (13) (14) (15) . Cannabis analysis in our laboratory is performed to Australian Standard AS/NZS 4308 (16) . Positive specimens from immunoassay screening test are confirmed by GC-MS analysis. In 2003, the number of specimens analyzed by GC-MS for THC-COOH confirmation alone was around 9000. This number increased to 14,000 in 2006. In response to increasing workloads for two years from 2005 to 2006, an automated solid-phase extraction (SPE) method was used to replace the previously manual liquid-liquid extraction method. Automated SPE was performed on a Gilson ASPEC XL4 SPE system. The SPE method increased significantly the throughput and reduced the manual handling tasks associated with the liquid-liquid extraction method. However, capping SPE cartridges for use on the ASPEC XIA system is physically demanding and thus becomes a manual handling hazard. Use of SPE cartridges and the caps also significantly increased laboratory running costs. The aim of this study was to develop and validate an alternative automated method for extracting THC-COOH from urine suited for GC-MS confirmation analysis without the use of SPE cartridges.
Materials and Methods
All reagents were analytical grade or better. THC-COOH standards as calibrators were from Alltech-Applied Science Labs (State College, PA). THC-COOH standards as quality control materials and THC-COOH-d9 (internal standard) were from Cerilliant (Austin, TX). Derivatizing reagents pentafluoropropionic anhydride (PFPA) and pentafluoropropanol (PFPOH) were from United Chemical Technologies (Bristol, PA).
Automated liquid-liquid extraction was performed on a four-probe Gilson ASPEC XL4 SPE system (John Morris Scientific, Sydney, Australia). GC-MS analysis was carried out on an Agilent 6890/5973 GC-MS equipped with an autoinjector and a HP-5MS 5% phenyl methyl siloxane crosslinked capillary GC column (30 m x 0.25-mm i.d., 0.25-~m film thickness, Agilent Technologies, Forest Hill, Australia). Pyrex test tubes (10 mL, 16 x 100 ram) with screw caps for manual extraction and borositicate culture tubes (9 mL, 13 x 100 ram) for automated extraction were from Crown Scientific (Sydney, Australia). Max Recovery Vials (1.5 mL) for fraction collection and GC-MS analysis were from United Chemical Technologies.
Hydrolysis
Urine samples (1 mL) were hydrolyzed for 20 min at room temperature after addition of 100 IJL 6 M NaOH and 50 IJL internal standard (2 lJg/mL THC-COOH-d9 in methanol).
Manual liquid-liquid extraction
Hydrolysis of urine was carried out in 10-mL Pyrex test tubes with screw caps. Into the hydrolyzed urine were added 800 IlL MeOH and 3 mL extracting solvent hexane/EtOAc (5:1, v/v). The capped test tubes were rolled on a roller-mix for 15 min followed by centrifugation at 2000 rpm for 5 rain. The upper organic phase was aspirated to waste. After addition of 3001JL 6 M HC1 and 1.5 mL hexane/EtOAc (5:1, v/v), the tubes were rolled for another 15 min. The tubes were centrifuged as described. Approximately 1 mL of the upper organic phase was transferred using a Pasteur pipette into a 1.5 mL max recovery GC-MS vial.
Automated liquid-liquid extraction
A standard SPE configuration was adapted and modified to perform liquid-Iiquid extraction tasks on the ASPEC XL4 SPE system. The sample rack used was Gilson Rack 43 holding up to 80 (4 x 20) specimens (Zone Specimen). The specimen zone was modified to hold a maximum of 76 specimens, leaving the last four positions for tubes storing 6 M HCI solutions (Zone HC1). The system also had 4 metal collection racks (Collect 143) holding up to 20 collection vials each (Zone Collect). A Teflon rod (16 mm x 12.3 mm) was placed into each hole on the rack to accommodate the use of the max recovery GC-MS vials for collecting extracts. The level of each collecting rack was also raised by using two stacked rack heighteners. The zone settings for DEC 143 Mobile Racks which hold SPE cartridges in SPE operation remained unchanged, although the mobile racks were not used in this application. Methanol was placed in Solvent D, and hexane/EtOAc (5:1, v/v) in Solvent A. The system rinsing solvent used was 30% methanol in water. Settings for needle heights in various zones in the tray configuration were as follows: 23 mm (Zone Specimen), 0 mm (Zone HCI), -10 mm (Zone DEC), 72 mm (Zone Collect).
In automated operation, hydrolysis of urine was carried out in 9-mL borosilicate culture tubes. The tubes were then placed into the Gilson sample rack (Rack 43). Methanol and the extracting solvent were delivered into urine tubes by the "dispense" function. The volume of extracting solvent added was the same as described in the manual process for the first cleanup extraction step, and different for the final extraction step (1.7 mL instead of 1.5 mL). Extraction was achieved by using the "mix" function which involved aspirating 1.3 mL of the upper organic layer and dispensing it into the lower aqueous layer at 15 mL/min for 10 cycles followed by mixing at 4 mL/min for 2 cycles. The upper organic phase in the clean-up extraction step was discarded into waste by using the "load" function. Hydrochloric acid (6 M, 28 mL in total) was placed in 4 sample tubes in positions 77-80 of the sample rack and dispensed into the urine mixture instead of via the solvent ports. Aliquots (1.3 mL) of the final extract were dispensed into the 1.5-mL max recovery vials. To avoid excessive solvent evaporation and potential sample contamination, aluminum foil was wrapped around the tubes in the specimen rack as well as around the whole area of the collection racks, with the aid of elastic bands and paper clips.
Derivatization
The extracts from the described manual or automated extraction process were evaporated to dryness under a gentle stream of nitrogen at 30~ The extracts were derivatized for 30 min at 60~ to 75~ with 25 IJL PFPA and 25 IJL PFPOH. After cooling to room temperature, the derivatives were evaporated to dryness under nitrogen and reconstituted in 1501JL hexane for GC-MS analysis.
GC-MS
Injections (2 IlL) were made in splitless mode with helium as a carrier gas at a constant flow of 1 mL/min. The inlet temperature was set to 240~ and the transfer line to 280~ The oven temperature was maintained at 180~ for 1 min and then programmed at 70~ to a final temperature of 300~ which was held for 3 rain. The MS was operated in the selective ion monitoring (SIM) mode. The ions monitored included m/z 622, 607, 473, and 459 for THC-COOH and rn/z 631,613, 482, and 468 for the internal standard THC-COOHd9. Ions 622 and 631 were used as quantifying ions, and others were used as qualifying ions. Quantification was based on the response ratios of THC-COOH to the internal standard (622/631).
Results
The limits of detection (LOD) and quantitation (LOQ) and upper limit of linearity (ULOL) were determined following conventional definitions, that is, acceptable retention times (+ 2%), ion ratios (• 20%) and quantitative values (_+ 20%). The LOD was subject to all criteria except the _+ 20% quantita-tive adherence. A three-point calibration was performed at concentrations of 10, 15, and 25 ng/mL by diluting the calibration standards into certified urine blank. The LOD, LOQ, and ULOL were determined at 1, 2, and 1500 ng/mL, respectively. A typical chromatogram for determining the LOD is shown in Figure 1 , demonstrating chromatography devoid of interfering peaks.
The accuracy and precision of the method were determined by analyzing quality control materials obtained from a different reputable supplier (Cerilliant in this case). Two quality control samples, LQC12.5 and HQC17.5, were analyzed daily with target concentrations at 12.5 and 17.5 ng/mL, respectively. Data collected over a three-month period were analyzed and shown in Table I . All three extraction methods, that is, manual liquid-liquid extraction, automated liquid-liquid extraction, and automated SPE, used in this laboratory over the last four years produced the same satisfactory results.
Four replicate specimens with a concentration of 25 ng/mL THC-COOH were analyzed by using both the manual and the automated extraction methods. The peak area of the quantifying ion (m/z 622) was compared to that without extraction which was normalized to 100%. The extraction efficiency after volume correction was found to be 84% for the automated method and 88% for the manual method, with %CV at 4,7 and 18.5 respectively.
Four patient urine specimens with high THC-COOH concentrations ranging from 5000 to 10,000 ng/mL were used for investigating potential carryover problems which might be associated with the automated process. Four certified urine blanks after addition of internal standards were processed immediately after the four strong positive specimens. There was no detectable THC-COOH in the urine blanks, indicating that there was no carryover after 10,000 ng/mL analyte. Two sets of identical patient specimens (n = 58) requiring GC-MS confirmation for THC-COOH were processed in parallel with manual extraction for one set and automated extraction for the other set. Excellent data concordance (R 2 > 0.995) was found for the two patient specimen sets (Figure 2) .
For a batch of 76 samples, the automated extraction process used less than 100 mL methanol, 450 mL extracting solvent hexane/ethyl acetate (5:1), and 1 L 30% methanol in water as rinsing solvent and took 5 h to complete. Figure 1 . A typical TIC and SIM profile for internal standard THC-COOH-d9 (RT 3.86 min) at 100 ng/mL and analyte THC-COOH (RT 3.88 min) at 1 ng/mL (LOD).
Discussion

GC-MS confirmation of urinary THC-COOH represents a large portion of the workload for many toxicology laboratories. Procedures for the extraction of THC-COOH by liquid-liquid and SPE methods have been previously published (17-21).
The major advantage of SPE over liquid-liquid extraction is its ease of automation. Automated SPE methods are becoming popular in many laboratories because of their better reproducibility, increased throughput, and reduction in labor costs (22) (23) (24) . Langen and co-workers (23) have published and documented a fully validated automated SPE method for THC-COOH extraction using a single probe Gilson ASPEC XL SPE system. A similar automated SPE method was developed in our laboratory on a four-probe Gilson ASPEC XL4 SPE system and was implemented in the period [2005] [2006] . The method performed comparably to the published one with similar recovery, accuracy, and precision but four times more sample throughput (unpublished data). The automated extraction method for THC-COOH described in this paper employs a Gilson ASPEC XIA SPE system without employing SPE cartridges. Liquid handling functions of the ASPEC XL4 systems (e.g., dispensing and mixing) are used to perform solvent delivering and urine-solvent mixing. Methanol and extracting solvent hexane/ EtOAc mixture are delivered into urine samples via solvent ports. Hydrochloric acid (6 M), being placed in sample tubes in positions 77 to 80 of the sample rack, is delivered to urine tubes by dispensing function. Under this configuration, the maximum number of specimens that can be processed in a batch is reduced slightly from 80 to 76. Any possible damage by the strong acid to solvent valves is eliminated as it is not delivered via solvent ports. The upper organic phase in the cleanup extraction step is discarded into waste by using the SPE function "load", which in an SPE process involves aspirating samples from the sample rack and dispensing the sample into SPE cartridges with the drain cuvettes underneath. The final extract is dispensed into collection vials for subsequent derivatization and GC-MS analysis. The method allows a batch of 76 specimens to be extracted and completed in 5 h, which is significantly shorter than the time required (8 h) to process the same amount of samples by the SPE method performed on the same instrument in this laboratory (unpublished data). Elimination of SPE cartridges from the extraction process not only significantly reduces the material cost but also removes the demanding manual handling task of capping cartridges for the SPE workstation. The newly developed method provides a speedy, simple, and economic alternative method for THC-COOH extraction with comparable performance (see Table I and Figure 2) .
The extracting solvent hexane/EtOAc is very volatile. To avoid excessive solvent evaporation at the mixing/extracting stages, the sample rack is covered with aluminum foil. The foil can also prevent any solvent spillage and thus possible sample contamination. For this same reason, the area for the collection vials is also covered with aluminum foil. The ASPEC XL4 system is programmed to work in a sequential mode instead of batch mode. In sequential mode, the system processes four samples at a time and completes the whole extraction Table I tasks before processing the next four samples. The major advantage of the sequential processing is that the needles and the connecting Teflon tubing only need to be rinsed thoroughly once at the end of each extraction cycle to prevent carryover contamination, compared to multiple rinses required in batch processing. It was found that 10 cycle of mixing at 15 mL/min provided adequate urine-organic solvent interaction without generating too much emulsion between the two phases. To avoid emulsion getting into the collection vials from the final extraction, several strategies have been introduced. Firstly, the needles are positioned 3-4 mm above the aqueous level in the sample tubes as the emulsified interface is usually 2-3 mm thick as illustrated in Figure 3B . Secondly, an excess volume of 100 to 200 IJL is programmed into the dispensing task to take care of excessive emulsion. Thirdly, a gentle mixing at 4 mL/min for 2 cycles following the vigorous mixing steps helps reducing the severity of emulsion. There are rare occasions when emulsions are so severe that some urine phases get into the collection vials. In these cases, the upper clear organic phases are transferred manually to clean collection vials.
For ease and simplicity of programming, the needle position in both extraction steps, that is, the clean-up extraction and the final extraction remains the same (Figure 3) . Consequently, there is approximately 500 I~L hexane/EtOAc extraction solvents in the clean-up step that is unreachable by the needles and thus remains in the tubes. However, these residual solvents have not been found to make any notable impact on the cleanness of the final extract. To obtain a cleaner extract, a larger extraction solvent volume (say 5 mL instead of 3 mL) can be used for the clean-up extraction. Alternatively, the clean-up extraction can be repeated twice to minimize any interfering substances in the residual extraction solvents. However, in practice, these strategies have been found unnecessary. Using 1.5-mL max recovery vials for extract collection offers significant advantages over conventional collection tubes. Once 
Conclusions
The newly developed automated liquid-liquid extraction method for THC-COOH extraction is comparable to both manual liquid-liquid extraction and automated SPE methods. It removes the costly SPE cartridge item from the automation process. It also removes the very demanding manual handling task of capping SPE cartridges for the ASPEC XL4 system. The developed method has been proven to be a simple, speedy, and economical alternative to the currently popular automated SPE method in drug analysis of urinary THC-COOH. The method may well be adapted and modified to work on other SPE workstations or liquid handlers following the principles and logic described and discussed in this paper.
